Clinical trial · Observational
Korean Practice Patterns for Screening PCA(Prostate Cancer)
Korean's Practice Patterns for Screening PCA(Prostate Cancer) According to PSA(Prostate-specific Antigen) Level
NCT01371513CI-TRIAL-00027725RESPECTcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is to investigate Korean urologist's practice patterns for screening prostate cancer according to PSA level.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Prostatic Hyperplasia | Benign Prostatic Hyperplasia | ONTOLOGY_EXACT | 0.98 |
| Neoplasms, Prostate | Prostate Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| continuous screening | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- PSA level
- description
- more than 2.5ng/ml
- interventionNames
- Other: continuous screening
Primary outcomes (1)
- measure
- Number of subjects with prostate biopsy
- timeFrame
- 1year
Secondary outcomes (1)
- measure
- Number of subjects with prostate cancer
- timeFrame
- 1year
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008 Exclusion Criteria: * Age less than 40 at PSA screening * History of drug use which can affect level of PSA within 6months before PSA screening * Subject who participate any other clinical trial
References
Publications (0)
Data not yet available
No reference posted for this study.